Search Within

Ciara Marie Kelly

Formats
  1. Meeting Abstract (44)
  2. Journal Article (37)
  3. Guidelines (4)
  4. Review (4)
  5. Book Section (1)
  6. Correspondence (1)
  7. Miscellaneous (1)
Groups
  1. Department of Medicine (92)
  2. Sarcoma Service (92)
  3. Solid Tumor Oncology Division (92)
  4. GSK Faculty (54)
  5. Hematologic Malignancies, Division of (54)
  6. Tow Center for Developmental Oncology (TCDO) (54)

More Groups

People
  1. William Tap (55)
  2. Sandra D'Angelo (51)
  3. Mark Dickson (48)
  4. Mrinal Gounder (48)
  5. Mary Keohan (46)
  6. Ping Chi (46)

More People

Years
  1. 2025 (5)
  2. 2024 (13)
  3. 2023 (10)
  4. 2022 (22)
  5. 2021 (7)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Clinical Cancer Research (10)
  3. Annals of Oncology (6)
  4. Journal for ImmunoTherapy of Cancer (6)
  5. Journal of the National Comprehensive Cancer Network (3)
  6. Nature Communications (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (33)
  2. American Association for Cancer Research (12)
  3. Oxford University Press (9)
  4. Biomed Central Ltd (7)
  5. Elsevier Inc. (4)
  6. Nature Publishing Group (4)

More Publishers

Results (92)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim results of a phase II trial of regional melphalan via limb infusion and systemic PD1 blockade in patients with extremity sarcoma
    Meeting Abstract

    Bartlett, E. K.; D'Angelo, S.; Kelly, C.; Rosenbaum, E.; Movva, S.; Erinjeri, J.; Fisher, C.; Singer, S.; Antonescu, C.; Ariyan, C.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • NOTOS: A pivotal study of navtemadlin, a first-in-class mouse double minute 2 inhibitor (MDM2i), in patients (pts) with TP53 wild-type (TP53(WT)) Merkel cell carcinoma (MCC) for whom anti PD-1/L1 therapy has failed
    Meeting Abstract

    Wong, M. K. K.; Burgess, M. A.; Chandra, S.; Fecher, L. A.; Gaudy-Marqueste, C.; Silk, A. W.; Hanna, G. J.; Lebbe, C.; Quéreux, G.; Rabinowits, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of first line retifanlimab (R) plus gemcitabine and docetaxel (GD) in patients (pts) with advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; Chan, J. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Distinct IDH1/2-associated methylation profile and enrichment of TP53 and TERT mutations distinguish dedifferentiated chondrosarcoma from conventional chondrosarcoma
    Journal Article

    Dermawan, J. K. T.; Nafa, K.; Mohanty, A.; Xu, Y.; Rijo, I.; Casanova, J.; Villafania, L.; Benhamida, J.; Kelly, C. M.; Tap, W. D.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
    Meeting Abstract

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Distinct IDH1/2-associated methylation profile and enrichment of TP53 and TERT mutations distinguish dedifferentiated chondrosarcoma from conventional chondrosarcoma on integrated genomic and epigenomic profiling
    Meeting Abstract

    Dermawan, J.; Nafa, K.; Mohanty, A.; Xu, Y.; Rijo, I.; Villafania, L.; Benhamida, J.; Kelly, C.; Tap, W.; Boland, P.; more...
    Journal of Molecular Diagnostics (2022)

    Fulltext@MSK | Save